Drug manufacturers would have to provide their rationale for increasing Rx drug prices by at least 10% in one year and 25% over three years under legislation that unanimously cleared the US House Ways & Means Committee April 9. They would also have to justify launch prices of at least $26,000.
The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, or the Prescription Drug STAR Act, H.R. 2113, has a good...